BRCA-MUTATED OVARIAN CARCINOMA

Clinical trials for BRCA-MUTATED OVARIAN CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new BRCA-MUTATED OVARIAN CARCINOMA trials appear

Sign up with your email to follow new studies for BRCA-MUTATED OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope: testing targeted drug before surgery for aggressive ovarian cancer

Disease control Ongoing

This early study is testing whether a drug called olaparib can help shrink tumors before surgery in people newly diagnosed with advanced ovarian cancer that has a BRCA gene mutation. The trial involves about 15 participants who will take olaparib pills for up to two months before…

Matched conditions: BRCA-MUTATED OVARIAN CARCINOMA

Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

BRCA-MUTATED OVARIAN CARCINOMA

Get alerted when new BRCA-MUTATED OVARIAN CARCINOMA trials appear

New hope: testing targeted drug before surgery for aggressive ovarian cancer